PTEN and plasma cell myeloma: (2) Target Diversity: Previous studies demonstrate tissue-specific targeting by miR-32-5p (BMP5 in colorectal, BTG2 in prostate, PTEN in myeloma), suggesting potential for novel targets in breast tissue.